Skip to main content

Wandering Baseline Artifact on ECG

Wandering Baseline Artifact

Ecg artifact
Baseline Wander (BW) Artifact on ECG 

One of the other major/common noise type on surface ecg is the baseline wander (BW).

BW recorded on ECG is mainly caused by the movement and respiration of the patient hence they appears as low-frequency artifacts!!!!

Generally these fluctuations on ECG are not of cardiac origin. And are typically in range below 0.5 Hz 


Issues with Baseline wander 

1. They can distort the ECG shape esp whenever there is body movement inc even deep rapid breathing !!! ( Some data even suggest that BW can even be caused by loose or dry electrodes) 


(To mitigate this issue remember Some techs may be used to ask patients to hold their breath during a 12-lead ECG. Be aware of this as this can also alter the patient’s heart rate) 


2. BW is especially important when subtle changes in the “low-frequency” ST–T segment are analyzed for the diagnosis of ischemia, for which ETT is performed . 

Though The frequency content of baseline wander is usually in the range below 0.5 Hz. However, increased movement of the body during the latter stages of ETT further increases the frequency content of baseline wander !!!


3. Patients unable to perform ETT may still be able to perform a stress test by either sitting or running an ergometer by hand. In such cases, BW related to motion of the arms severely distorts the ECG signal. Remember The bandwidth of such BW is considerably larger than that caused by respiratory activity and perspiration.


Data shows that Removal of BW is very essential and lots of efforts & Reaserch have been put in world wide ,to decrease the changes in beats morphology which do not have cardiac origin. 

(Techniques like linear filtering and polynomial fitting are used to remove baseline wander from ECG signals)


Thanks 😊 

Comments

Popular posts from this blog

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 ESC Guidelines on INR Targets in Mechanical Valves

  2025 ESC Guidelines on INR Targets in Mechanical Valves INR Targets in Patients With Mechanical Heart Valves Updated, guideline-oriented review Mechanical heart valves are inherently thrombogenic and require lifelong anticoagulation. Vitamin K antagonists, particularly warfarin, remain the standard therapy. The international normalized ratio (INR) is used to guide anticoagulation intensity and must be individualized based on valve type, valve position, and patient-related thromboembolic risk factors. Subtherapeutic INR increases the risk of valve thrombosis and systemic embolism, whereas excessive anticoagulation increases bleeding risk. Why INR control is critical Mechanical valves promote thrombosis due to non-physiological blood flow, high shear stress, and continuous contact between blood and artificial surfaces. These prothrombotic mechanisms persist for life. Direct oral anticoagulants are contraindicated in mechanical valves; therefore, VKAs remain mandatory. The goal of I...